WAYNE, Pa.--(BUSINESS WIRE)--The prompt and accurate detection of bacteremia and fungemia is one of the most important functions of clinical microbiology laboratories. Guidelines for the collection, ...

Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...

WAYNE, Pa.--(BUSINESS WIRE)--Implementing best practices during the collection and handling of blood specimens and fulfilling quality management system requirements during preexamination procedures ...

The tables presented in CLSI M100 represent the most current information for drug selection, interpretation, and quality control using the procedures defined in CLSI standards CLSI M02, M07, and M11.

MALVERN, PA — The Clinical & Laboratory Standards Institute (CLSI) has announced its partnership with the LymeX Diagnostics Prize to support Phase 4 of the competition, a critical stage aimed at ...

Nancy Dubrowny, MS, MT(ASCP)SC, BD Preanalytical Systems, and chairholder of the subcommittee that developed the guideline, says, "One benefit of this document is that it provides a recommendation for ...

Zaynich (zidebactam/cefepime- WCK 5222) has been granted a susceptibility breakpoint of 64 mg/L for around 10 gram negative pathogens showing high resistance rates by the Clinical and Laboratory ...

The development of more user-friendly, affordable, and versatile mass spectrometers, as well as the availability of stable isotopes that serve as internal standards to facilitate more accurate ...

Flow cytometry assay validation requires different analytical approaches in preclinical and clinical settings. A fit-for-purpose (FFP) strategy allows researchers to customize the validation to ...

MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) — Clinical & Laboratory Standards Institute (CLSI) is proud to announce its partnership with LymeX Diagnostics Prize to support teams entering Phase 4 of ...